Aster Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Aster Capital Management's RCUS Position: Q3 2026 in Review
Aster Capital Management opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 1 share worth $26. The stake represents ﹤0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RCUS as recently as Q3 2025.
Aster Capital Management first reported a position in RCUS in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.18K in Q3 2025. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Aster Capital Management held 1 share of Arcus Biosciences worth $26 as of Q3 2026.
- Arcus Biosciences was a new Aster Capital Management position in Q3 2026.
- Arcus Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #956 holding.
- Aster Capital Management first reported a position in Arcus Biosciences in Q4 2024 and has held it in 3 quarters since.
- Aster Capital Management's Arcus Biosciences position peaked at $3.18K in Q3 2025.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.